Month: March 2026

NextPlat Reports $54 Million in Revenue for Full Year 2025 as Business Turnaround Initiatives Support Operational Profitability Goals in 2026

Refocusing and Cost Cutting Efforts Now Delivering Operational Improvement Including Sequential Margin Expansion and Significant Cost ReductionsHALLANDALE BEACH, Fla., March...

OpenProtein.AI Expands Strategic Partnership with Boehringer Ingelheim to Advance AI-Driven Antibody Discovery

Boehringer Ingelheim expands its collaboration with OpenProtein.AI following successful initial deployment, co-developing integrated workflows for next-generation therapeutic development.NEW YORK, March...

University of Toledo Health Scales Nabla’s Ambient AI After Unlocking Better Documentation Precision and Revenue Cycle Performance

Health system reports faster chart closure, reduced documentation burden, and improved operational efficiency across multiple specialtiesNEW YORK, March 31, 2026...

n6 Appoints Broad Institute Principal Investigator Aziz Al’Khafaji as Scientific Advisor, Advancing AutoNorm™ as the New Standard in NGS Library Preparation

Pioneering genomics researcher and Methods Development Lab director joins n6 to accelerate adoption of AutoNorm across the research and clinical...

Infinx Named as a Representative Vendor in Gartner(R) 2026 Market Guide for Intelligent Prior Authorization, U.S. Healthcare Organizations

CUPERTINO, CA / ACCESS Newswire / March 31, 2026 / Infinx Healthcare, a technology-enabled revenue cycle solutions provider, announced today...

TRNR Reports Record Full-Year 2025 Results, Driven by 114% Revenue Growth; Confirms 2026 Guidance of $30M+ in Pro Forma Revenue & $0.5M Stock Repurchase Program

Full-Year Net Loss of $24.0 Million; Full Year Adjusted EBITDA Loss of Approximately $9.6 Million2025 Revenue would have been $20.7...

4basebio announces major expansion to support the growing demand of RUO and HQ synthetic DNA with lease of an innovation hub and manufacturing facility in Cambridge, UK

4basebio PLC ("4basebio" or the "Company") Cambridge, UK, 31 March 2026 – 4basebio PLC (AIM: 4BB), a specialist in synthetic...

error: Content is protected !!